Business Context and Reporting Period
Park Ha Biological Technology Co., Ltd. (Nasdaq: BYAH), a Cayman Islands exempted company, filed this Form 6-K for the month of June 2026. The filing reports the entry into material agreements regarding a private placement offering that closed on June 15, 2026.
Key Financial Metrics
- Gross Proceeds: Approximately $2.0 million from the sale of 1,133,332 Class A ordinary shares and pre-funded warrants for up to 200,000 additional shares.
- Offering Price: $1.50 per Class A Ordinary Share and Pre-Funded Warrant.
- Placement Agent Fees: 8.0% cash success fee of aggregate gross proceeds, plus non-accountable and out-of-pocket expenses capped at $70,000.
- Use of Proceeds: Working capital and general corporate purposes.
- Revenue, Profit, and Cash Flow: The filing text does not provide a clear value for these operational metrics.
- Debt and Liquidity: The filing text does not provide a clear value for current debt levels or liquidity ratios outside of the new proceeds.
Material Changes
The primary material change is the completion of a "best-efforts" offering on June 15, 2026, resulting in the issuance of new equity and pre-funded warrants. This transaction increases the company's share count and cash reserves. The filing does not provide comparative financial data to quantify changes in revenue or profitability versus prior periods.
Guidance, Outlook, and Risks
- Management Commentary: The company intends to utilize net proceeds for working capital and general corporate purposes.
- Forward-Looking Statements: The filing includes standard disclaimers that actual results may differ materially from expectations due to known and unknown risks.
- Risks and Contingencies: The Securities Purchase Agreement (SPA) and Placement Agency Agreement (PAA) contain customary representations, warranties, covenants, and indemnification provisions. The pre-funded warrants are exercisable immediately at $0.00001 per share.
- Unusual Items: None reported beyond the standard terms of the equity offering.
Investor Verification Checklist
- Verify the exact number of shares issued and the final dilution impact on existing shareholders.
- Confirm the net proceeds after deducting the 8.0% placement fee and the capped $70,000 in expenses.
- Review the full text of the Securities Purchase Agreement (Exhibit 10.2) for specific covenants or restrictions.
- Check subsequent filings for the company's updated cash position and burn rate following the June 15 closing.